Gene · 5670
Papers3,544
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,544
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Strategies for Surface Design in Surface Plasmon Resonance (SPR) Sensing. | Biosensors (Basel) | 2023 | 37185540 | PubTator, text mining | PubMed |
| A Case of Cushing's Syndrome from Well-Differentiated Neuroendocrine Tumors of the Small Bowel and Its Mesentery. | Curr Oncol | 2023 | 37185425 | PubTator, text mining | PubMed |
| IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study. | Kidney Int Rep | 2023 | 37180506 | PubTator, text mining | PubMed |
| MicroRNA Dysregulation in Early Breast Cancer Diagnosis: A Systematic Review and Meta-Analysis. | Int J Mol Sci | 2023 | 37175974 | PubTator, text mining | PubMed |
| Efficacy of Lymph Node Location-Number Hybrid Staging System on the Prognosis of Gastric Cancer Patients. | Cancers (Basel) | 2023 | 37174124 | PubTator, text mining | PubMed |
| Molecularly imprinted polymers (MIPs): emerging biomaterials for cancer theragnostic applications. | Biomater Res | 2023 | 37173721 | PubTator, text mining | PubMed |
| The inflammatory prognostic index as a potential predictor of prognosis in metastatic gastric cancer. | Sci Rep | 2023 | 37173358 | PubTator, text mining | PubMed |
| Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations. | Cancer Med | 2023 | 37165917 | PubTator, text mining | PubMed |
| Proteomic characteristics reveal the signatures and the risks of T1 colorectal cancer metastasis to lymph nodes. | Elife | 2023 | 37158593 | PubTator, text mining | PubMed |
| Targeting MFAP5 in cancer-associated fibroblasts sensitizes pancreatic cancer to PD-L1-based immunochemotherapy via remodeling the matrix. | Oncogene | 2023 | 37156839 | PubTator, text mining | PubMed |
| Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer. | Front Immunol | 2023 | 37153618 | PubTator, text mining | PubMed |
| Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogeneity of PET-CT. | Comput Struct Biotechnol J | 2023 | 37153537 | PubTator, text mining | PubMed |
| Recent development of surface-enhanced Raman scattering for biosensing. | J Nanobiotechnology | 2023 | 37149605 | PubTator, text mining | PubMed |
| Glutathione peroxidase 2 knockdown suppresses gastric cancer progression and metastasis via regulation of kynurenine metabolism. | Oncogene | 2023 | 37138031 | PubTator, text mining | PubMed |
| SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022). | Clin Transl Oncol | 2023 | 37133732 | PubTator, text mining | PubMed |
| Intraductal Tubulopapillary Neoplasm Diagnosed Before Surgery: A Case Report. | Cureus | 2023 | 37131554 | PubTator, text mining | PubMed |
| Development and validation of a contrast-enhanced CT-based radiomics nomogram for preoperative diagnosis in neuroendocrine carcinoma of digestive system. | Front Endocrinol (Lausanne) | 2023 | 37124722 | PubTator, text mining | PubMed |
| Primary monophasic synovial sarcoma of the lung: Rare case report. | Radiol Case Rep | 2023 | 37123038 | PubTator, text mining | PubMed |
| Isolation and Characterization of Extracellular Vesicles in Human Bowel Lavage Fluid. | Int J Mol Sci | 2023 | 37108550 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Breast Cancer: From Biology and Function to Clinical Diagnosis and Therapeutic Management. | Int J Mol Sci | 2023 | 37108371 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5670/papers?page=19